SCHEMBL7879920

SCHEMBL7879920

CNC(N)=NC(=O)c1cc2c(C(F)(F)F)cc(OCc3cccc(CN)c3)cc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.37
MRGPRX4 Q96LA9 4/20 0.36
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CFD P00746 1/20 0.35
AR P10275 1/20 0.35
MAOA P21397 1/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR4A2 P43354 1/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877982 0.94 MAOB (0.37) MAOBARMAOAIDO1TDO2
SCHEMBL7881398 0.91 MAOB (0.36) MAOBMRGPRX4MAPTHTTL3MBTL1
Hydrochloric Acid SCHEMBL7881834 0.90 IDO1 (0.40) MAOBARMAOAKDM4EALDH1A1
SCHEMBL7877573 0.89 GYS1 (0.36) MAOBMRGPRX4MAPTHTTL3MBTL1
SCHEMBL7877894 0.88 RHEB (0.36)
SCHEMBL7877991 0.87 MAOB (0.38) MAOBMRGPRX4CFDMAOA
SCHEMBL7882032 0.86 MAOB (0.39) MAOBARMAOAKDM4ESMN1; SMN2
SCHEMBL7882326 0.86 RHEB (0.32) AR
SCHEMBL7873348 0.85 RHEB (0.38) ARIDO1TDO2
SCHEMBL7879946 0.84 MAOB (0.35) MAOBAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed